Effects of mud-bath treatment on fibromyalgia patients: a randomized clinical trial

Authors: Fioravanti A (1) , Perpignano G (2) , Tirri G (3) , Cardinale G (4) , Giannitti C (1) , Lanza CE (1) , Loi A (2) , Tirri E (3) , Sfriso P (4) , Cozzi F (4)
(1) Rheumatology Unit, Department of Clinical Medicine and Immunological Sciences, University of Siena (2) Rheumatology Unit, University of Cagliari (3) Rheumatology Unit, II University of Napoli (4) Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova
Source: Rheumatol Int. 2007 Oct;27(12):1157-61
DOI: 10.1007/s00296-007-0358-x Publication date: 2007 Oct E-Publication date: May 23, 2007 Availability: abstract Copyright: Not specified
Language: English Countries: Italy Location: Not specified Correspondence address: Not specified


Article abstract

The efficacy of balneotherapy in fibromyalgia syndrome (FS) has been well demonstrated, while controlled studies using mud packs are lacking. We performed a randomized clinical trial to evaluate the effects and the tolerability of mud-bath treatment in FS patients, who are poor responders to pharmacological therapy. Eighty patients with primary FS, according to ACR criteria, were randomly allocated to two groups: 40 were submitted to a cycle of 12 mud packs and thermal baths, and 40 were considered as controls. At baseline, after thermal treatment and after 16 weeks, patients were evaluated by FIQ, tender points count, VAS for "minor" symptoms, AIMS1 and HAQ. Control patients were assessed at the same time periods. A significant improvement of all evaluation parameters after mud-bath therapy and after 16 weeks was observed. Mud packs were well tolerated and no drop-outs were recorded. Our results suggest the efficacy and the tolerability of mud-bath treatment in primary FS.

Find it online